Clinical Trials Logo

Hand Dermatoses clinical trials

View clinical trials related to Hand Dermatoses.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05471934 Completed - Hand Eczema Clinical Trials

Satisfaction Survey - Cicaplast Mains

Start date: February 2014
Phase:
Study type: Observational

The participants presenting with hand problems and meeting the inclusion criteria are asked to apply the study product for one month. They are evaluated before and after treatment.

NCT ID: NCT04136574 Completed - Hand Dermatoses Clinical Trials

Hand Dermatitis in the Care and Hospital Staff

MANUS-PRO
Start date: July 1, 2019
Phase:
Study type: Observational

Study of the prevalence and risk factors of occupational dermatitis in the hands of caregivers and hospital staff of the Brest CHRU.

NCT ID: NCT03617068 Completed - Hand Dermatoses Clinical Trials

The Effectiveness of Coconut Oil Cream as a Prevention Treatment for Occupational Hand Dermatitis Among Batik Workers

Start date: February 6, 2017
Phase: Phase 3
Study type: Interventional

Empirically, mosturizer is used to prevent and treat many occupational dermatoses that has skin barrier impairment. Evidence based medicine about the effectivity of mosturizer in occupational dermatoses is limited. Coconut oil is one of traditional substance that is used as a skin care. There is study shows that coconut oil is effective for atopic dermatitis treatment in children. Other studies are needed to assess the effectivity coconut oil mosturizer cream to overcome occupational hand dermatitis.

NCT ID: NCT00890968 Completed - Hand Dermatoses Clinical Trials

Safety and Efficacy Study of Triamcinolone Acetonide DuraPeel to Treat Hand Dermatitis

TAC-202
Start date: April 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether Triamcinolone Acetonide (TAC) DuraPeel is safe and effective in the treatment of hand dermatitis.

NCT ID: NCT00843466 Completed - Hand Dermatosis Clinical Trials

Compatibility of a Mild, Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis

Start date: May 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to find out if the use of a hand cleanser that adds moisture to the skin will help improve skin rashes caused by frequent hand washing (hand dermatitis).

NCT ID: NCT00828464 Completed - Hand Dermatosis Clinical Trials

Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis

Start date: October 2008
Phase: Phase 4
Study type: Interventional

The purpose of the study is to assess the safety, efficacy and tolerability of Clobetasol propionate foam in subjects with chronic dermatitis.

NCT ID: NCT00309621 Completed - Hand Dermatoses Clinical Trials

Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis

Start date: April 2006
Phase: Phase 3
Study type: Interventional

Patients with severe chronic hand dermatitis, that has not responded to topical treatment, including topical steroids and the avoidance of aggravating factors, will be treated with the oral medication alitretinoin. The study aims to investigate the safety and efficacy of the medication when given over a period of 6 months.

NCT ID: NCT00124475 Completed - Hand Dermatoses Clinical Trials

Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis

Start date: December 2004
Phase: Phase 3
Study type: Interventional

The purpose of the study is to determine the therapeutic effect of alitretinoin, a retinoid, on severe, therapy refractory chronic hand dermatitis.

NCT ID: NCT00124436 Completed - Hand Dermatoses Clinical Trials

Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis

Start date: March 2005
Phase: Phase 3
Study type: Interventional

Patients who have been treated in study protocol BAP089 may have responded to treatment, and subsequently relapsed to >75% of the baseline disease severity, will be investigated for response to further treatment with alitretinoin. Also, patients who have responded with mild or moderate disease will be investigated for additional treatment effect after prolongated treatment.